Sanofi offers to remedy EU’s antitrust concerns over flu vaccine (update*)
By Lewis Crofts ( July 8, 2026, 09:45 GMT | Insight) -- French pharma company Sanofi will make public declarations for up to four years to correct the potentially anticompetitive impact of claims about a rival flu treatment. The move is designed to address concerns raised by the European Commission, and could lead to the end of the probe without formal sanction.French pharma company Sanofi will make public declarations for up to four years to correct the potentially anticompetitive impact of claims about a rival flu treatment....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.